This week we are going to discuss a relatively rare but painful condition called cervical dystonia or spasmodic torticollis. Cervical dystonia is a condition of adulthood that generally occurs after ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Cervical Dystonia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...

After debuting in the aesthetics market with Daxxify last year, Revance has made its way to the potentially lucrative therapeutic space. With a Monday FDA nod to treat cervical dystonia in adults, ...

When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind. However, there are other equally debilitating and much less well-known ...

The US Food and Drug Administration (FDA) has expanded the indiction for daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) for the treatment of cervical dystonia in adults, the ...

Recent discoveries made by researchers from Charité – Universitätsmedizin Berlin may prove vital in improving the treatment of dystonia, a neurological movement disorder. Published in PNAS, their ...

NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced positive topline results ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the company will present an ...

Shares of Revance Therapeutics Inc. RVNC gained 8% premarket on Monday after the U.S. Food and Drug Administration approved the biotech company’s Daxxify injection for treatment of cervical dystonia ...

A Columbia resident with cervical dystonia, a chronic and painful disorder causing involuntary spasms of neck muscles, won a national contest that will award $10,000 to the Bethesda Naval Hospital to ...